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Background
Transcatheter aortic valve implantation (TAVI) offers a
minimal invasive option for treatment of patients with
severe aortic stenosis at high risk for conventional surgery.
The objective of this study was to investigate whether pre-
sence of late gadolinium enhancement (LGE) patterns
detected by cardiac magnetic resonance imaging (cMRI) is
a risk factor for major adverse cardiac events (MACE)
after TAVI within the first 30 days.
Methods
77 consecutive patients with severe aortic stenosis (aor-
tic valve area <1cm2) underwent cMRI on a 1.5 Tesla
MR Scanner (Achieva, Philips, The Netherlands) with
gadolinium contrast agent (Dotarem, Guerbet, France)
before transcatheter aortic valve implantation (TAVI).
Measurements of left ventricular (LV) and right ventri-
cular (RV) volumes, ejection fraction (EF), stroke
volume (SV) and LGE patterns (no LGE, transmural,
subendocardial scar, midwall fibrosis and fibrosis of the
right ventricular insertion points) were determined.
Clinical characteristics and 30 days outcome were corre-
lated with cMRI measurements. MACE included death,
myocardial infarction, stroke and reintervention.
Results
Mean age of patients was 83 +/-5 years, 66% of the
patients were female. 58 patients showed LGE patterns
on MRI: 8 patients had midwall fibrosis, 19 patients had
infarct-like myocardial LGE(6 subendocardial scars,
13 transmural scars) and 46 patients had fibrosis of the
right ventricular insertion points (31 as single pattern,
15 as combined pattern). Patients with infarct like LGE
had worse LVEF than patients with no scar (no scar:
66.5 ± 16%, infarct like scar: 41 ±19%, p=0.01).
Patients with midwall fibrosis more often reported syn-
copal events before admission (p=0.05) and had worse
right ventricular function (RVEF<50%) then patients
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without LGE (p=0.04). 30 day-MACE was low (5%),
2 patients died (asystolia and combination of severe cardial
complications and sepsis) and 2 patients suffered a stroke.
MACE was significant higher in patients with midwall
fibrosis (p=0.05), however not in the other LGE-groups.
Left bundle branch block (p=0.5), high degree AV- block
(p=0.9), need of permanent pacemaker (p=0.3), cardiac
decompensation (p=0.7), TIA (p=0.9) and rehospitalization
(p=0.4) did not show significant differences between the
groups.
Conclusions
Different late gadolinium enhancement patterns exist in
patients with aortic stenosis. The presence of LGE of any
cause does not appear to predict MACE within the first
30 days. However, MACE was significantly higher in
patients with midwall fibrosis. Studies with more patients
have to be performed to investigate whether midwall fibro-
sis in patients scheduled for TAVI is a risk factor for this
patient group.
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